Key Highlights
•
A new drug called RO8323, which targets proteins CDK8 and CDK19, was shown to reduce organ transplant rejection in a study. This is important because it works by boosting helpful immune cells and calming harmful ones, offering a potential new way to help patients keep their transplanted organs.
Source →
•
A study found that the drug burosumab significantly improves growth in children and adolescents with X-linked hypophosphatemia, a rare genetic disorder that causes short stature. This real-world evidence suggests the treatment can help these patients achieve a greater adult height.
Source →
•
A network analysis of treatments for sacroiliac joint pain, a common cause of chronic low back pain, found that radiofrequency-based procedures consistently provided better pain relief and reduced disability compared to steroid injections or conservative care. This helps clarify which interventional options may be most effective for patients suffering from this condition.
Source →
•
A large study of patients with hepatitis C found that both successful antiviral treatment and the use of cholesterol-lowering statin drugs were independently linked to a lower risk of severe liver complications. This means that for patients with hepatitis C, statins may offer an additional benefit to protect liver health beyond curing the viral infection.
Source →
•
A survey in the UK found that most hospitals stopped routinely prescribing long-acting opioid pills for post-surgery pain after a safety warning, but communication with patients and doctors about the risks of opioids remains poor. This highlights a critical gap in patient safety that needs to be addressed even when prescribing guidelines change.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
